NorthWest Biotherapeutics Inc (NWBO)

[Troymister]

From Stansberry Venture Technology:

Bean counters at Big Pharma got tired of paying the research costs for so many clinical-trial failures. Instead, the new business model is to let investors take the risk... then Big Pharma steps in to buy the successes.

Fortunately, this means picking the right small firms can lead to huge gains when the takeover happens.

Most small firms have no sales force, and Big Pharma companies have thousands of field reps. So there's a virtuous economic payoff when the big companies and smaller firms get together.

The hard part is finding the successes before the Big Pharma sharks can beat us to them. That's what we specialize in at Stansberry Venture Technology. We use three drug guidelines when recommending a company...

*Minimal side effects. We figure that as long as they're safe, the drugs we back could still be supplemental drugs even if a better treatment is developed in the future.
*Strong positive effects. By that, I simply mean that the drug works and does what doctors need it to do.
*Huge market potential. We like to see treatments that can help hundreds of thousands of people per year, if not millions.
Plus – and this is important – we focus on early-stage clinical trials. These are Phase I and Phase II trials, when researchers have moved past animal testing into treating people with the diseases.